Astellas, MBC BioLabs call for scientists to enter 'Golden Ticket Competition'

By The Science Advisory Board staff writers

September 29, 2020 -- Astellas Venture Management and Mission Bay Capital BioLabs (MBC BioLabs) are collaborating again on the "Golden Ticket Competition," which offers up to two scientists or emerging biotechnology startups one-year access to state-of-the-art laboratory space and access to Astellas' scientists and business leaders.

The competition is a joint effort by the companies to support scientists and early-stage companies to accelerate their novel therapeutic programs, modalities, or platforms. For 2020, the companies are interested in all areas of discovery and new innovations for unmet medical needs, that align with Astellas' focus area approach.

The inaugural competition was held in 2019, where AmbAgon Therapeutics and Gordian Biotechnology were chosen as the winners.

The competition is open from September 29 to October 27, 2020. Entrepreneurial scientists and emerging life science or biotechnology startups should submit their nonconfidential company presentation, including a one-page executive summary, to to be considered.

Illumina Accelerator announces new genomics startups
Illumina has chosen seven companies to join the first global cohort of Illumina Accelerator, its startup incubator that partners with entrepreneurs to...
Agilent to fund biotherapy incubator in India
Agilent Technologies has announced a partnership with the Indian Institute of Technology Delhi to advance biotherapeutic research in the country.

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter